Remove Drug Development Remove Packaging Remove Pharma Companies Remove Pharmaceutical Companies
article thumbnail

Scandinavia: insight into opportunities for drug discovery

Drug Discovery World

The weakness connected to that is we have so few large pharmaceuticals. The pharma companies that are based in Sweden, are international ones, and often have a marketing and commercial side but maybe not that drug development side that really brings that key focus area between the development and commercialisation.”

Science 130
article thumbnail

Reflections on life science’s regulatory environment  

Drug Discovery World

Remco Munnik (RM): Up to now, regulatory has always been the spider in the web within a pharmaceutical company – collecting all of the relevant information for submission of the registration: Clinical, CMC, administrative data, etc – then compiling a valid eCTD by the submission deadline.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What it takes to make cancer research more inclusive

Drug Discovery World

These observations may come to light in the clinic, but these disparities can be attributed to every phase of the drug development pipeline – clinical trials, translational research and, ultimately, drug discovery. . Cancer health disparities and underlying contributing factors .

Research 130
article thumbnail

Scaling Phage Therapy

Codon

The weakened dose of phages helped bacteria develop resistance, and the trial became yet another study that provided evidence phages are safe, but little more. To learn more about how bacteria and other microbes develop resistance, check out the CDC’s information sheet on AMR. I cover this more extensively in The Good Virus.

Therapies 118